|
1
|
Swetter SM and Elston DM: Cutaneous
Melanoma. Medscape, pp1-35, 2019.
|
|
2
|
Rocken M, Schaller M, Sattler E and
Burgdorf W: Color atlas of dermatology. Thieme, Stuttgart,
pp256-261, 2012.
|
|
3
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Piñeros M, Znaor A, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer, Lyon, 2020.
|
|
4
|
Rotaru M, Jitian CR and Iancu GM: A
10-year retrospective study of melanoma stage at diagnosis in the
academic emergency hospital of Sibiu county. Oncol Lett.
17:4145–4148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Calomarde-Rees L, García-Calatayud R,
Requena Caballero C, Manrique-Silva E, Traves V, García-Casado Z,
Soriano V, Kumar R and Nagore E: Risk factors for lymphatic and
hematogenous dissemination in patients with stages I to II
cutaneous melanoma. JAMA Dermatol. 155:679–687. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tejera-Vaquerizo A, Ribero S, Puig S,
Boada A, Paradela S, Moreno-Ramírez D, Cañueto J, de Unamuno B,
Brinca A, Descalzo-Gallego MA, et al: Survival analysis and
sentinel lymph node status in thin cutaneous melanoma: A
multicenter observational study. Cancer Med. 8:4235–4244.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cherobin AC, Wainstein AJ, Colosimo EA,
Goulart EM and Bittencourt FV: Prognostic factors for metastasis in
cutaneous melanoma. An Bras Dermatol. 93:19–26. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mervic L: Time course and pattern of
metastasis of cutaneous melanoma differ between men and women. PLoS
One. 7(e32955)2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non-melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Swetter SM, Thompson JA, Albertini MR,
Barker CA, Baumgartner J, Boland G, Chmielowski B, DiMaio D, Durham
A, Fields RC, et al: Melanoma: Cutaneous, Version 2.2021, NCCN
Clinical Practice Guidelines in Oncology, pp1-225, 2021.
|
|
12
|
Thompson JF, McCarthy WH, Bosch CM,
O'Brien CJ, Quinn MJ, Paramaesvaran S, Crotty K, McCarthy SW, Uren
RF and Howman-Giles R: Sentinel lymph node status as an indicator
of the presence of metastatic melanoma in regional lymph nodes.
Melanoma Res. 5:255–260. 1995.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Krengel S, Hauschild A and Schäfer T:
Melanoma risk in congenital melanocytic naevi: A systematic review.
Br J Dermatol. 155:1–8. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Morton DL, Thompson JF, Cochran AJ,
Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo
CA, Coventry BJ, et al: Final trial report of sentinel-node biopsy
versus nodal observation in melanoma. N Engl J Med. 370:599–609.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Swerdlow AJ, English JS and Qiao Z: The
risk of melanoma in patients with congenital nevi: A cohort study.
J Am Acad Dermatol. 32:595–599. 1995.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Clark WH Jr, Elder DE, Guerry D IV,
Epstein MN, Greene MH and Van Horn M: A study of tumor progression:
The precursor lesions of superficial spreading and nodular
melanoma. Hum Pathol. 15:1147–1165. 1984.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Grob JJ, Gaudy-Marqueste G, Kha KB,
Johnson TM, Durham AB, Dummer R and Goldinger SM: Melanoma. In:
Rooks Textbook of Dermatology. Griffiths CEM, Barker J, Bleiker T,
Chalmers R and Creamer D (eds). John Wiley & Sons Ltd.,
Chinchester, pp3973-4008, 2016.
|
|
18
|
Wagner T, Buscombe J, Gnanasegaran G and
Navalkissoor S: SPECT/CT in sentinel lymph node imaging. Nucl Med
Commun. 34:191–202. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Egger ME, Stevenson M, Bhutiani N, Jordan
AC, Scoggins CR, Philips P, Martin RCG II and McMasters KM: Age and
lymphovascular invasion accurately predict sentinel lymph node
metastasis in T2 melanoma patients. Ann Surg Oncol. 26:3955–3961.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jaukovic L, Rajović M, Kandolf Sekulovic
L, Radulovic M, Stepic N, Mijuskovic Z, Petrov N and Ajdinovic B:
Time to procedure, nuclear imaging and clinicopathological
characteristics as predictive factors for sentinel lymph node
metastasis in cutaneous melanoma: A single-center analysis. Ann
Plast Surg. 81:80–86. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Munsch C, Lauwers-Cances V, Lamant L,
Gentil C, Rochaix P, Garrido I, Lopez R, Chevreau C, Paul C and
Meyer N: Breslow thickness, clark index and ulceration are
associated with sentinel lymph node metastasis in melanoma
patients: A cohort analysis of 612 patients. Dermatology.
229:183–189. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
White RL Jr, Ayers GD, Stell VH, Ding S,
Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ,
et al: Factors predictive of the status of sentinel lymph nodes in
melanoma patients from a large multicenter database. Ann Surg
Oncol. 18:3593–3600. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cordeiro E, Gervais MK, Shah PS, Look Hong
NJ and Wright FC: Sentinel lymph node biopsy in thin cutaneous
melanoma: A systematic review and meta-analysis. Ann Surg Oncol.
23:4178–4188. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Karakousis G, Gimotty PA, Bartlett EK, Sim
MS, Neuwirth MG, Fraker D, Czerniecki BJ and Faries MB: Thin
melanoma with nodal involvement: Analysis of demographic,
pathologic, and treatment factors with regard to prognosis. Ann
Surg Oncol. 24:952–959. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Abdel-Rahman O: Clinical correlates and
prognostic value of different metastatic sites in patients with
malignant melanoma of the skin: A SEER database analysis. J
Dermatolog Treat. 29:176–181. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Protocol for the examination of specimens
from patients with melanoma of the skin. College of American
Pathologists, 2011. Available from: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SkinMelanoma_11protocol.pdf.
|
|
27
|
Brauer JA, Wriston CC, Troxel AB,
Elenitsas R, Shin DB, Guerry D and Ming ME: Characteristics
associated with early and late melanoma metastases. Cancer.
116:415–423. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sinnamon AJ, Neuwirth MG, Yalamanchi P,
Gimotty P, Elder DE, Xu X, Kelz RR, Roses RE, Chu EY, Ming ME, et
al: Association between patient age and lymph node positivity in
thin melanoma. JAMA Dermatol. 153:866–873. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cohn-Cedermark G, Månsson-Brahme E,
Rutqvist LE, Larsson O, Singnomklao T and Ringborg U: Metastatic
patterns, clinical outcome, and malignant phenotype in malignant
cutaneous melanoma. Acta Oncol. 38:549–557. 1999.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Medalie N and Ackerman AB: Sentinel node
biopsy has no benefit for patients whose primary cutaneous melanoma
has metastasized to a lymph node and therefore should be abandoned
now. Br J Dermatol. 151:298–307. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Clark WH: Tumour progression and the
nature of cancer. Br J Cancer. 64:631–644. 1991.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Heenan PJ: Local recurrence of melanoma.
Pathology. 36:491–495. 2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Conic RRZ, Ko J, Damiani G, Funchain P,
Knackstedt T, Vij A, Vidimos A and Gastman BR: Predictors of
sentinel lymph node positivity in thin melanoma using the national
cancer database. J Am Acad Dermatol. 80:441–447. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
White RL Jr, Ayers GD, Stell VH, Ding S,
Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ,
et al: Factors predictive of the status of sentinel lymph nodes in
melanoma patients from a large multicenter database. Ann Surg
Oncol. 18:3593–3600. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Callender GG, Egger ME, Burton AL,
Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC II and
McMasters KM: Prognostic implications of anatomic location of
primary cutaneous melanoma of 1 mm or thicker. Am J Surg.
202:659–665. 2011.PubMed/NCBI View Article : Google Scholar
|
